Sonidegib
Back to searchMolecule Structure
Scientific Name
Sonidegib
Description of the Drug
Sonidegib is an antineoplastic agent used for the treatment of locally advanced recurrent basal cell carcinoma (BCC) following surgery and radiation therapy, or in cases where surgery or radiation therapy are not appropriate.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09143
http://www.drugbank.ca/drugs/DB09143
Brand Name(s)
Not Available
Company Owner(s)
Sun Pharmaceutical Industries Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Smoothened homolog | SINGLE PROTEIN | INHIBITOR | CHEMBL5971 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL554455 | ||
| DrugBank | DB09143 | ||
| PubChem: Thomson Pharma | 49697167 | ||
| PubChem | 24775005 | ||
| LINCS | LSM-4938 | ||
| Nikkaji | J3.351.814E | ||
| BindingDB | 50394562 | ||
| DrugCentral | 5008 | ||
| ChemicalBook | CB52515129 | ||
| Guide to Pharmacology | 8199 | ||
| rxnorm | ODOMZO | SONIDEGIB | SONIDEGIB PHOSPHATE |
| ChEBI | 90863 | ||
| ZINC | ZINC000068202099 |
